Intended for healthcare professionals


Chlamydia screening can have high take-up rates if right methodology is used

BMJ 1999; 319 doi: (Published 17 July 1999) Cite this as: BMJ 1999;319:188
  1. John Macleod, Clinical research fellow,
  2. George Davey Smith, Professor of clinical epidemiology
  1. Department of General Practice, University of Birmingham, Birmingham B15 2TT
  2. Department of Social Medicine, University of Bristol, Bristol BS8 2PR

    EDITOR—A report by the expert advisory group to the chief medical officer suggested that a screening programme in the United Kingdom for Chlamydia trachomatis should be based around the opportunistic testing of women attending primary care and the tracing of their contacts.1 Duncan and Hart discuss some of the possible negative consequences of this decision.2 There are some further reasons why the Department of Health's stated strategy is a bad idea.

    Chlamydia screening has …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription